Journals / Türk Uyku Tıbbı Dergisi / 2019 / Cilt: 6 - Sayı: 1

A Case of Secondary Hypersomnia Associated with Amlodipine

Amlodipin ile İlişkili İkincil Hipersomni Olgusu

Pages
16–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, a patient who was followed up with the diagnosis of idiopathic hypersomnia, but was diagnosed as hypersomnia associated with amlodipine use along with conditions that Obstructive Sleep Apnea syndrome and delayed sleep phase syndrome may cause excessive daytime sleepiness, was presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Excessive daytime sleepiness is a symptom which can caused serious problems in patients life and is widely common in general population.
📊
Key Findings & Data:It may be occurred depending on drug use and medical conditions.
💡
Conclusion & Impact:In this case report, a patient who was followed up with the diagnosis of idiopathic hypersomnia, but was diagnosed as hypersomnia associated with amlodipine use along with conditions that Obstructive Sleep Apnea syndrome and delayed sleep phase syndrome may cause excessive daytime sleepiness, was presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Excessive daytime sleepiness is a symptom which can caused serious problems in patients life and is widely common in general population. It may be occurred depending on drug use and medical conditions. Secondary reasons must be investigated before making the diagnosis of primary hypersomnia in patients with excessive daytime sleepiness. In this case report, a patient who was followed up with the diagnosis of idiopathic hypersomnia, but was diagnosed as hypersomnia associated with amlodipine use along with conditions that Obstructive Sleep Apnea syndrome and delayed sleep phase syndrome may cause excessive daytime sleepiness, was presented.

Özet

Gün içi aşırı uykululuk hastaların yaşamlarında ciddi sorunlara yol açabilmektedir ve genel popülasyonda oldukça yaygın görülen bir semptomdur. İlaç kullanımına ve medikal durumlara bağlı olarak da ortaya çıkabilmektedir. Gün içi aşırı uykululuğu olan hastalarda birincil hipersomni tanısı konulmadan önce ikincil nedenler mutlaka araştırılmalıdır. Bu olgu sunumunda idiyopatik hipersomni tanısı ile takip edilen ancak aşırı gün içi uykululuğa neden olabilecek durumlar arasında Obstrüktif Uyku Apne sendromu ve geçikmiş uyku fazı mevcut olmakla birlikte hipersomni durumunun öncelikle amlodipin ile ilişkili olduğu tespit edilen bir hasta sunulmuştur.

🔖

Cite This Article

KOÇ, G., AKÇAY, B. D., YETKİN, S. (2019). A Case of Secondary Hypersomnia Associated with Amlodipine. Türk Uyku Tıbbı Dergisi, Cilt: 6 - Sayı: 1, 16–18. https://ajindex.com/articles/327940

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd edition. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2014
  2. Yetkin S Özgen F. Hipersomnili Hastanın Değerlendirilmesi. Türkiye Klinikleri Journal of Internal Medicine Sciences, Uyku ve Uyku Bozuklukları Özel Sayısı 2007;3:13-8
  3. Berkowski JA, Shelgikar AV. Disorders of Excessive Daytime Sleepiness Including Narcolepsy and Idiopathic Hypersomnia. Sleep Med Clin 2016;11:365-78
  4. Perez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10(Suppl 1):S112-S23
  5. Billiard M, Dauvilliers Y. Idiopathic Hypersomnia. Sleep Med Rev 2001;5:349-58
  6. Bulsara KG, Cassagnol M. Amlodipine. 2018 Aug 14. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from
  7. Mohan JC, Jain R, Chamle V, Bhargava A. Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide. J Clin Diagn Res 2015;9:OC10-3
  8. NORVASC (amlodipine besylate) [Highlights of Prescribing Information] Pfizer Labs; Available from: http://www.accessdata. fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf [updated Revised: May 2011
  9. Elliott WJ, Bistrika EA. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opin Drug Saf 2018;17:207-16
  10. Van Gastel A. Drug-Induced Insomnia and Excessive Sleepiness. Sleep Med Clin 2018;13:147-59
  11. Trotti LM. Idiopathic Hypersomnia. Sleep Med Clin 2017;12:331-44
  12. Benbir Şenel G. Pathophysiology, signs and symptoms in snoring and obstructive sleep apnea syndrome. Turkiye Klinikleri Ear Nose and Throat- Special Topics 2018;(3):1-8
  13. Savrun Y, Demir AB, Sıvacı AÖ, Bora İ, Zarifoğlu M. Our Cases of Secondary Narcolepsy with Three Different Etiology: Review of the Literature. J Turk Sleep Med 2015;(3):72-6
  14. Koç G Akçay BD, Karadaş Ö, Yetkin S. A Case of Pleiosomnia Following Traumatic Brain Injury. J Turk Sleep Med 2017;4:90-4.